COYA Earnings

Quarterly EPS
$-0.26
Q3 2024
$-0.18
Q4 2024
$-0.44
Q1 2025
$-0.36
Q2 2025
$-0.13
Q3 2025
$-0.34
Q4 2025
$-0.32
Q1 2026
$-0.28
Q2 2026
Latest Revenue243.7K
Latest Net Income-6638260
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.28243.7K-6638260+49.0%+22.2%
Q1 2026-$0.32251.1K-7206990-2.6%+27.3%
Q4 2025-$0.344.0M-5708542+202,768.8%-88.9%
Q3 2025-$0.133.6M-2115831+50.0%
Q2 2025-$0.36163.6K-6094977-95.2%-89.5%
Q1 2025-$0.44257.9K-7306757+103.3%-25.7%
Q4 2024-$0.182.0K-2915776-100.0%-263.6%
Q3 2024-$0.260-4021418+23.5%
Q2 2024-$0.193.4M-2891680
Q1 2024-$0.35126.8K-5051913
Q4 2023$0.116.0M1.3M
Q3 2023-$0.340-3421974
Coya Therapeutics (COYA) — Earnings